佰奥智能（300836）(300836.SZ)披露2025年度业绩预告，公司预计归属于上市公司股东的净利润9000 万元至1.2亿元，同比增长228.34%至337.79%;扣除非经常性损益后的净利润8600万元至1.16亿元，同比 增长220.72%至332.60%。 ...

Group 1 - The company Baiao Intelligent (300836.SZ) has disclosed its performance forecast for the year 2025, expecting a net profit attributable to shareholders of between 90 million to 120 million yuan, representing a year-on-year growth of 228.34% to 337.79% [1] - The net profit after deducting non-recurring gains and losses is anticipated to be between 86 million to 116 million yuan, with a year-on-year increase of 220.72% to 332.60% [1]

每经AI快讯，1月21日，佰奥智能（300836）(300836.SZ)发布2025年度业绩预告，预计归属于上市公司 股东的净利润为9,000万元~12,000万元，比上年同期增长228.34%~337.79%。报告期内，公司开拓新领 域市场，产业链布局优化；消费电子及工业品市场需求回暖，智能设备投入增加，消费电子领域的盈利 能力稳步上升；火工品及含能材料相关领域业务产能持续释放，产能利用率持续提高，规模化效应显 现；持续加大在AI智能配套产品等前沿领域的研发投入与市场渗透。 ...

南财智讯1月21日电，"佰奥智能"发布年度业绩预告，预计2025年全年归属于上市公司股东的净利润为 9000万元—12000万元，同比预增228.34%—337.79%；预计2025年全年归属于上市公司股东的扣除非经 常性损益的净利润为8600万元—11600万元，同比预增220.72%—332.60%，报告期内，公司业绩大幅增 长，主要原因为：1、报告期内，公司不断开拓新的领域市场，深耕产业链上下游，持续提升运营效率 与成本费用管控能力，完善各应用领域的业务布局和产品结构，2025年营业收入实现了大幅增长，盈利 能力大幅提升。2、报告期内，随着消费电子及工业品市场需求回暖与技术升级，客户对智能设备投入 需求显著提升，进一步提升了公司消费电子领域市场份额的增长。同时，公司智能技术创新与产品迭代 升级，不断推动对产品结构的优化，公司消费电子领域的盈利能力稳步上升。3、公司火工品及含能材 料相关领域业务产能持续释放，带动营业收入稳定增长。伴随订单的稳定交付，公司产能利用率持续提 高，规模化效应显现，公司盈利能力显著提升。4、公司继续加大研发投入，加速多元化业务战略布 局，持续加大在AI智能配套产品等前沿领域的研发 ...

佰奥智能公告，预计2025年度净利润为9000万元～1.2亿元，同比增长228.34%～337.79%。报告期内， 公司不断开拓新的领域市场，深耕产业链上下游，持续提升运营效率与成本费用管控能力，完善各应用 领域的业务布局和产品结构，2025年营业收入实现了大幅增长，盈利能力大幅提升。 ...

证券代码：300836 证券简称：佰奥智能 公告编号：2026-001 昆山佰奥智能装备股份有限公司 2025 年度业绩预告 本公司及董事会全体成员保证信息披露的内容真实、准确、完整，没有虚假记载、误导 性陈述或重大遗漏。 一、本期业绩预计情况 1、业绩预告期间：2025 年 1 月 1 日至 2025 年 12 月 31 日。 2、业绩预告情况：预计净利润为正值且属于同向上升 50%以上情形 （1）以区间数进行业绩预告的 三、业绩变动原因说明 报告期内，公司业绩大幅增长，主要原因为： 1、报告期内，公司不断开拓新的领域市场，深耕产业链上下游，持续提升 运营效率与成本费用管控能力，完善各应用领域的业务布局和产品结构，2025 年营业收入实现了大幅增长，盈利能力大幅提升。 2、报告期内，随着消费电子及工业品市场需求回暖与技术升级，客户对智 能设备投入需求显著提升，进一步提升了公司消费电子领域市场份额的增长。同 时，公司智能技术创新与产品迭代升级，不断推动对产品结构的优化，公司消费 电子领域的盈利能力稳步上升。 3、公司火工品及含能材料相关领域业务产能持续释放，带动营业收入稳定 增长。伴随订单的稳定交付，公司产能 ...

Group 1 - The specialized equipment sector increased by 0.52% on January 16, with Hu Ning Co., Ltd. leading the gains [1] - The Shanghai Composite Index closed at 4101.91, down 0.26%, while the Shenzhen Component Index closed at 14281.08, down 0.18% [1] - Hu Ning Co., Ltd. saw a closing price of 29.51, with a significant increase of 15.50% and a trading volume of 111,000 shares, amounting to a transaction value of 322 million yuan [1] Group 2 - The specialized equipment sector experienced a net inflow of 5.9259 million yuan from institutional investors, while retail investors saw a net inflow of 90.3058 million yuan [2] - Major stocks in the sector showed varied performance, with some experiencing significant declines, such as Nanxing Co., Ltd. which fell by 10.01% [2] - The data indicates a mixed sentiment among investors, with institutional funds showing a net outflow while retail investors were net buyers [2][3]

证券日报网讯1月13日，佰奥智能（300836）在互动平台回答投资者提问时表示，公司密切关注航空航 天领域发展机遇，2025年通过的大型国有航天客户的重大中标，实现航天领域业务落地，涵盖发动机、 弹箭等核心领域，涉及具体合作项目、客户信息属于公司商业秘密，请以公司公告为准。 ...

证券日报网讯1月13日，佰奥智能（300836）在互动平台回答投资者提问时表示，目前公司生产经营状 况良好，在手订单充足，整体保持较高的产能利用率水平。 ...

Group 1 - Sichuan Chengyu's wholly-owned subsidiary plans to acquire 85% equity of Hubei Jingyi Company for 2.409 billion yuan, enhancing the company's control over highway projects [1] - Huadian Technology signed contracts worth approximately 815 million yuan with Huadian Technology Group for a wind power hydrogen production project [2] - Dongfang Cable and its subsidiary won projects totaling approximately 3.125 billion yuan, accounting for 34.37% of the company's audited revenue for 2024 [3] Group 2 - Heng Rui Medicine received approval for clinical trials of SHR-2906 injection, a self-developed biopharmaceutical aimed at weight control and metabolic regulation [4] - Qingdao Port plans to invest approximately 15.7 billion yuan in two terminal projects [5] - Jingu Co. received a notification to supply low-carbon wheels for two export models to a major domestic car manufacturer, with production expected in 2026 [6] Group 3 - ST Xingguang won a procurement project worth approximately 22.955 million yuan, accounting for 11.96% of the company's revenue for 2024 [7] - Xinbo Co. plans to jointly invest in an alloy materials research institute with partners, focusing on high-performance materials for various industries [8] - Tianqi Lithium's third-phase lithium concentrate expansion project has been completed and is undergoing trial production, with a total capacity of 2.14 million tons per year [9] Group 4 - Changfei Fiber reported that new fiber optic products related to data centers represent a small proportion of total demand [10] - Dongfang Bio's subsidiaries obtained multiple medical device registration certificates, including various testing kits [11] - Xiugang Co. plans to use up to 500 million yuan of idle fundraising for cash management in safe, liquid investment products [12] Group 5 - Jifeng Co. received a project designation for passenger car seat assemblies from a European luxury brand, with a total lifecycle value of approximately 9.8 billion yuan [13] - CanSino initiated Phase I clinical trials for a combined vaccine, completing the first subject enrollment [14] - Dayu Water-saving's subsidiary pre-won a drainage project worth 140 million yuan and another project worth 1 billion yuan [15] Group 6 - Yutong Pharmaceutical's subsidiary received clinical trial approval for YKYY032 injection for treating hyperlipoproteinemia [17] - Diweier announced the departure of a core technical personnel, impacting its technical leadership [18] - Weilang Co.'s controlling shareholder received regulatory measures from the Shandong Securities Regulatory Bureau for failing to fulfill a commitment [19] Group 7 - Xiehe Electronics invested 5 million yuan in a private equity fund focusing on hard technology sectors [20] - Phoenix Optical received a government subsidy of 4.7053 million yuan, representing 35% of its projected net profit for 2024 [21] - China State Construction reported a 0.9% year-on-year increase in new contracts signed in the first 11 months of 2025, totaling 4.0408 trillion yuan [22] Group 8 - Nanguang Energy's pumped storage power station units 1 and 2 have entered trial operation, with units 3 and 4 expected to follow by year-end [23] - Jindalai plans to invest 280 million yuan to acquire a 34% stake in Yunnan Jici Medical Technology [24] - Geer Software terminated its planned acquisition of a majority stake in Weipin Zhiyuan due to failure to reach agreement on key terms [25] Group 9 - Ningbo Fubang completed the absorption merger of its wholly-owned subsidiary, inheriting all assets and liabilities [26] - Zhongyuan Neipei signed a strategic cooperation framework agreement with Ningbo Puzhi Company for humanoid robot-related business [28] - Gongyuan Co. announced a business integration and relocation of its production lines in the East China region [29] Group 10 - Chlor-alkali Chemical's subsidiary plans to invest 2.975 billion yuan in a comprehensive utilization project for waste salt [30] - Kain Technology announced the departure of a core technical personnel, impacting its research capabilities [31] - ST Renfu received approval for clinical trials of a new drug for idiopathic pulmonary fibrosis [32] Group 11 - Sanbo Brain Science's established brain science fund has completed registration with the Asset Management Association of China [33] - Tongyou Technology plans to apply for a 70 million yuan credit line from Beijing Bank, using its property as collateral [34] - Bai Ao Intelligent signed a significant equipment sales contract worth approximately 27.5021 million yuan [35] Group 12 - ST Xinyan received all restructuring investment funds totaling 2.239 billion yuan, entering the execution phase of its restructuring plan [36] - Dalu Real Estate's subsidiary decided to terminate a planned acquisition of a 60% stake in Beijing Chengzhu Real Estate [38] - Huiyu Pharmaceutical's products received marketing approval in Italy and Norway [39]